Skip to main content

Advertisement

SpringerLink
Log in

The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Patients with unresectable pancreatic and biliary cancers sometimes need decompression due to obstruction of the gastrointestinal tract and/or biliary tract. The aim of this study was to determine the prognostic factors associated with an indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers.

Methods

Between April 2005 and September 2011, 37 patients with unresectable pancreatic and biliary cancers underwent palliative bypass surgery. Prognostic factors were searched for among clinical characteristics, operation-related factors, and tumor-related factors using a prospective database.

Results

The median survival time (MST) of these patients was 4.6 months, with a 6-month survival rate of 40.5 %. A multivariate Cox proportional hazards regression analysis revealed that mGPS >2 was the only independent prognostic factor for bypass surgery. Patients with an mGPS of 2 had an MST of 1.7 months, and they had a significantly worse prognosis than mGPS 0–1 patients with an MST of 6.3 months.

Conclusions

The mGPS is useful for predicting survival after surgical decompression due to gastrointestinal obstruction in patients with unresectable pancreatic and biliary cancers. Patients with a poor mGPS may not be indicated for palliative bypass surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Li D, Xie K, Wolff R, Abbruzzese JL et al (2004) Pancreatic cancer. Lancet 363:1049–1057

    Article  CAS  PubMed  Google Scholar 

  2. Sahani DV, Shah ZK, Catalano OA et al (2008) Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 23:23–33

    Article  PubMed  Google Scholar 

  3. Nagakawa T, Kayahara M, Ikeda S et al (2009) Biliary tract cancer treatment: results from the biliary tract cancer statistics registry in Japan. J Hepatobiliary Pancreat Surg 9:569–575

    Article  Google Scholar 

  4. Nakakura EK, Warren RS (2007) Palliative care for patients with advanced pancreatic and biliary cancers. Surg Oncol 16:293–297

    Article  PubMed  Google Scholar 

  5. McMillan DC, Crozier JE, Canna K et al (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Color Dis 22:881–886

    Article  Google Scholar 

  6. Kneuertz PJ, Cunningham SC, Cameron JL et al (2011) Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. J Gastroint Surg 15:1917–1927

    Article  Google Scholar 

  7. Maltoni M, Caraceni A, Brunelli C, Steering Committee of the European Association for Palliative Care, et al (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations––a study by the steering committee of the European Association for Palliative Care. J Clin Oncol 23:6240–6248

    Google Scholar 

  8. McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12:223–226

    Article  PubMed  Google Scholar 

  9. Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Fut Oncol 6:149–163

    Article  CAS  Google Scholar 

  10. O’Gorman P, McMillan DC, McArdle CS (2000) Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Can 37:36–40

    Article  Google Scholar 

  11. Yamashita H, Katai H (2010) Systemic inflammatory response in gastric cancer. World J Surg 34:2399–2400

    Article  PubMed  Google Scholar 

  12. Forrest LM, McMillan DC, McArdle CS et al (2005) A prospective longitudinal study of performance status, anti-inflammation-based score (GPS) and survival in patients with inoperable non-small cell lung cancer. Br J Can 92:1834–1836

    Article  CAS  Google Scholar 

  13. Al Murri AM, Bartlett JM, Canney PA et al (2006) Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Can 94:227–230

    Article  CAS  Google Scholar 

  14. Glen P, Jamieson NB, McMillan DC et al (2006) Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6:450–453

    Article  PubMed  Google Scholar 

  15. Ramsey S, Lamb GW, Aitchison M et al (2007) Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Cancer 109:205–212

    Article  PubMed  Google Scholar 

  16. Shimoda M, Katoh M, Kita J et al (2010) The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer. Chemotherapy 56:501–506

    Google Scholar 

  17. Dutta S, Al-Mrabt NM, Fullarton GM et al (2011) A comparison of POSSUM and GPS models in the prediction of post-operative outcome in patients undergoing oesophago-gastric cancer resection. Ann Surg Oncol 18:2808–2817

    Article  PubMed  Google Scholar 

  18. Roxburgh CS, Salmond JM, Horgan PG et al (2009) Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 249:788–793

    Article  PubMed  Google Scholar 

  19. Lamb GW, Aitchison M, Ramsey S et al (2012) Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems. Br J Can 106:279–283

    Google Scholar 

  20. Jamieson NB, Denley SM, Logue J et al (2011) A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma. Ann Surg Oncol 18:2318–2328

    Article  PubMed  Google Scholar 

  21. Horino K, Beppu T, Kuroki H et al (2012) Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma. Int J Clin Oncol [Epub ahead of print]

  22. Krishnan S, Rana V, Janjan NA et al (2006) Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer 107:2589–2596

    Article  CAS  PubMed  Google Scholar 

  23. Thieblemont C, Grossoeuvre A, Houot R et al (2008) Non-Hodgkin’s lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome. Ann Oncol 19:774–779

    Article  CAS  PubMed  Google Scholar 

  24. Engelken FJ, Bettschart V, Rahman MQ et al (2003) Prognostic factors in the palliation of pancreatic cancer. Eur J Surg Oncol 29:368–373

    Article  CAS  PubMed  Google Scholar 

  25. Costamagna G, Pandolfi M (2004) Endoscopic stenting for biliary and pancreatic malignancies. J Clin Gastroenterol 38:59–67

    Article  PubMed  Google Scholar 

  26. Maire F, Hammel P, Ponsot P et al (2006) Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol 101:735–742

    Article  PubMed  Google Scholar 

  27. Graber I, Dumas R, Filoche B et al (2007) The efficacy and safety of duodenal stenting: a prospective multicenter study. Endoscopy 39:784–787

    Article  CAS  PubMed  Google Scholar 

  28. Cheng HT, Tsou YK, Lin CH et al (2011) Endoscopic metal stents for the palliation of malignant upper gastroduodenal obstruction. Hepatogastroenterology 58:1998–2002

    PubMed  Google Scholar 

  29. Jeurnink SM, van Eijck CH, Steyerberg EW et al (2007) Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol 7:18

    Article  PubMed Central  PubMed  Google Scholar 

  30. Jeurnink SM, Steyerberg EW, van Hooft JE et al (2010) Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 71:490–499

    Article  PubMed  Google Scholar 

  31. Hochwald SN, Burke EC, Jarnagin WR et al (1999) Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 134:261–266

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan

    Yoshiaki Ikuta, Hiroshi Takamori, Yasuo Sakamoto, Daisuke Hashimoto, Akira Chikamoto, Hideyuki Kuroki, Kazuya Sakata, Keita Sakamoto, Hiromitsu Hayashi, Katsunori Imai, Hidetoshi Nitta, Masahiko Hirota, Keiichiro Kanemitsu, Toru Beppu & Hideo Baba

Authors
  1. Yoshiaki Ikuta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Takamori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuo Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daisuke Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akira Chikamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hideyuki Kuroki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazuya Sakata
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Keita Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hiromitsu Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Katsunori Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hidetoshi Nitta
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Masahiko Hirota
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Keiichiro Kanemitsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Toru Beppu
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Hideo Baba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hideo Baba.

About this article

Cite this article

Ikuta, Y., Takamori, H., Sakamoto, Y. et al. The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers. Int J Clin Oncol 19, 629–633 (2014). https://doi.org/10.1007/s10147-013-0613-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-013-0613-y

Keywords

Search

Navigation